Synthesis and Antibacterial Activity of New 6″-Modified Tobramycin Derivatives
Kseniya S Shapovalova, Georgy V Zatonsky, Elizaveta A Razumova, Daria A Ipatova, Dmitrii A Lukianov, Petr V Sergiev, Natalia E Grammatikova, Alexander S Tikhomirov, Andrey E Shchekotikhin, Maria Fernanda N N Carvalho, Tsz Tin Yu · 2024
Read Synthesis and Antibacterial Activity of New 6″-Modified Tobramycin Derivatives by Kseniya S Shapovalova, Georgy V Zatonsky, Elizaveta A Razumova, Daria A Ipatova, Dmitrii A Lukianov, Petr V Sergiev, Natalia E Grammatikova, Alexander S Tikhomirov, Andrey E Shchekotikhin, Maria Fernanda N N Carvalho, Tsz Tin Yu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11672562.txt.
Description
Kseniya Shapovalova and co-authors remodel the antibiotic tobramycin to outwit resistant bacteria, in this 2024 study. Tobramycin belongs to an old, broad antibiotic family now blunted by resistance and harsh side effects. The team attached new chemical tails at one chosen position of the molecule.
The new versions matched the parent drug against standard strains and far outdid it against resistant clinical isolates, where the parent nearly failed. They also worked around a common resistance mutation in gut bacteria. Cell tests showed lower toxicity than the parent, and the killing mechanism stayed the same: garbled protein building.
Catalog record
| CREATOR | Kseniya S Shapovalova, Georgy V Zatonsky, Elizaveta A Razumova, Daria A Ipatova, Dmitrii A Lukianov, Petr V Sergiev, Natalia E Grammatikova, Alexander S Tikhomirov, Andrey E Shchekotikhin, Maria Fernanda N N Carvalho, Tsz Tin Yu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |